{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:17:59Z","timestamp":1772165879382,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["8246120517"],"award-info":[{"award-number":["8246120517"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project for Public Health Talent Cultivation of China","award":["Guo Jikong Zong Ren Han [2024]122"],"award-info":[{"award-number":["Guo Jikong Zong Ren Han [2024]122"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22543-4","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T01:28:17Z","timestamp":1744334897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Examining the efficacy of treatment outcomes for patients with pulmonary tuberculosis in Western China: A retrospective study in a region of high incidence"],"prefix":"10.1186","volume":"25","author":[{"given":"Jian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"22543_CR1","volume-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization; 2023."},{"key":"22543_CR2","volume-title":"Analysis of National tuberculosis epidemic characteristics and multi-regional incidence prediction from 2004 to 2014","author":"X Yang","year":"2017","unstructured":"Yang X. Analysis of National tuberculosis epidemic characteristics and multi-regional incidence prediction from 2004 to 2014. Lanzhou: Lanzhou University; 2017."},{"key":"22543_CR3","volume-title":"Statistical analysis of the distribution characteristics of tuberculosis incidence in China","author":"LP Lu","year":"2019","unstructured":"Lu LP. Statistical analysis of the distribution characteristics of tuberculosis incidence in China. Lanzhou: Lanzhou University of Finance and Economics; 2019."},{"key":"22543_CR4","volume-title":"Study on Spatial distribution characteristics and influencing factors of tuberculosis","author":"LJ Yang","year":"2020","unstructured":"Yang LJ. Study on Spatial distribution characteristics and influencing factors of tuberculosis. Beijing: Chinese Center for Disease Control and Prevention; 2020."},{"key":"22543_CR5","unstructured":"Jiang H, Liu MY, Zhang YJ. Study on the Change regularity of Tuberculosis epidemic in China from 2005 to 2016\/\/ Compilation of papers of the 33rd National Academic Conference of China Tuberculosis Prevention Association and China Tuberculosis Science and Technology Award Presentation Conference. Qingdao: China National Tuberculosis Association, Chongqing Zhifei Biological Products Co., LTD., 2021:176\u2013177."},{"key":"22543_CR6","first-page":"1541","volume":"47","author":"J Zhou","year":"2020","unstructured":"Zhou J, Chen HJ, Hong F, Li JL. Analysis on the characteristics of tuberculosis patients in Guizhou Province from 2013 to 2018. Mod Prev Med. 2020;47:1541\u20136.","journal-title":"Mod Prev Med"},{"issue":"06","key":"22543_CR7","first-page":"557","volume":"24","author":"XL Guo","year":"2019","unstructured":"Guo XL, Chen HJ, Yu LI, Zhou J, ZHOU JJ, Ma XX, et al. Prevalence characteristics of drug-resistant tuberculosis in Lifuping, Guizhou Province from 2016 to 2020. Chin J Prev Med. 2019;24(06):557\u201361.","journal-title":"Chin J Prev Med"},{"issue":"1","key":"22543_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12879-022-07499-9","volume":"22","author":"W Yun","year":"2022","unstructured":"Yun W, Huijuan C, Long L, Xiaolong L, Aihua Z. Time trend prediction and spatial-temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014\u20132020. BMC Infect Dis. 2022;22(1):525.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"22543_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3760\/cma.j.issn.0254-6450.2019.05.013","volume":"40","author":"Y Liu","year":"2019","unstructured":"Liu Y, Xu CH, Wang ZY, Wang XM, Wang YH, Zhang H, et al. Investigation on the fnancial burden of tuberculosis patients in designated tuberculosis hospitals in China. Chin J Epidemiol. 2019;40(5):559\u201364. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2019.05.013.","journal-title":"Chin J Epidemiol"},{"issue":"6","key":"22543_CR10","first-page":"401","volume":"13","author":"WB Li","year":"2012","unstructured":"Li WB, Li XX, Zhang H, LI RZ, Cheng J, Wang LX, et al. Investigation on the status quo of medical security for non-drug-resistant tuberculosis patients in diferent regions of China. Chin J Prev. 2012;13(6):401\u20135. doi: CNKI: SUN: ZGYC. 0. 2012-06-003.","journal-title":"Chin J Prev"},{"issue":"3","key":"22543_CR11","first-page":"267","volume":"36","author":"CY Li","year":"2019","unstructured":"Li CY, Cai XF, Yuan M. Analysis of mental health status and risk factors of pulmonary tuberculosis patients treated in our hospital in recent three years. Chin Health Stat. 2019;36(3):267\u20139. doi:CNKI:SUN:ZGWT.0.2019-02-029.","journal-title":"Chin Health Stat"},{"issue":"4","key":"22543_CR12","first-page":"366","volume":"42","author":"T Fu","year":"2020","unstructured":"Fu T, Huang LJ, Yang JJ, Yao Z, Xiao H. Analysis of 308 cases of MDR-TB patients\u2019 mental health status and its risk factors. Chin J De?F Consum. 2020;42(4):366\u201371. doi:CNKI:SUN:ZFLZ.0.2020-04-014.","journal-title":"Chin J De?F Consum"},{"issue":"1","key":"22543_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12916-019-1487-2","volume":"18","author":"M Klopper","year":"2020","unstructured":"Klopper M, Heupink TH, Hill-Cawthorne G, Streicher EM, Dippenaar A, de Vos M, et al. A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic. BMC Med. 2020;18(1):24. https:\/\/doi.org\/10.1186\/s12916-019-1487-2.","journal-title":"BMC Med"},{"issue":"4","key":"22543_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.15446\/rsap.V20n4.50575","volume":"20","author":"VJ G\u00f3mez-Tangarife","year":"2018","unstructured":"G\u00f3mez-Tangarife VJ, G\u00f3mez-Restrepo AJ, Robledo-Restrepo J, Hern\u00e1ndez-Sarmiento JM. Resistencia a medicamentos En Mycobacterium tuberculosis: Contribuci\u00f3n de mecanismos constitutivos y adquiridos [Drug resistance in Mycobacterium tuberculosis: contribution of constituent and acquired mechanisms]. Rev Salud Publica (Bogota). 2018;20(4):491\u20137. https:\/\/doi.org\/10.15446\/rsap.V20n4.50575.","journal-title":"Rev Salud Publica (Bogota)"},{"issue":"9","key":"22543_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2119430","volume":"387","author":"F Conradie","year":"2022","unstructured":"Conradie F, Bagdasaryan TR, Borisov S, Howell P, Mikiashvili L, Ngubane N, et al. Bedaquiline-Pretomanid-Linezolid regimens for Drug-Resistant tuberculosis. N Engl J Med. 2022;387(9):810\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2119430.","journal-title":"N Engl J Med"},{"key":"22543_CR16","doi-asserted-by":"publisher","unstructured":"Seddon JA, Garcia-Prats AJ, Purchase SE, Osman M, Demers AM, Hoddinott G et al. Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TMDR-TBB-CHAMP).Trials.2018;19(1):693.https:\/\/doi.org\/10.1186\/s13063-018-3070-0","DOI":"10.1186\/s13063-018-3070-0"},{"issue":"5","key":"22543_CR17","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.3346\/jkms.2023.38.e33","volume":"38","author":"H Choi","year":"2023","unstructured":"Choi H, Mok J, Kang YA, Jeong D, Kang HY, Kim HJ, et al. Nationwide treatment outcomes of patients with Multidrug\/Rifampin-Resistant tuberculosis in Korea, 2011\u20132017: A retrospective cohort study (Korean TB-POST). J Korean Med Sci. 2023;38(5):e33. https:\/\/doi.org\/10.3346\/jkms.2023.38.e33.","journal-title":"J Korean Med Sci"},{"key":"22543_CR18","doi-asserted-by":"publisher","unstructured":"Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.Lancet.2018;392(10150):821\u201334.https:\/\/doi.org\/10.3346\/jkms.2023.38.e33","DOI":"10.3346\/jkms.2023.38.e33"},{"issue":"8","key":"22543_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.5588\/ijtld.18.0408","volume":"22","author":"JA Caminero","year":"2018","unstructured":"Caminero JA, Scardigli A. The economic burden of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2018;22(8):831\u20132. https:\/\/doi.org\/10.5588\/ijtld.18.0408.","journal-title":"Int J Tuberc Lung Dis"},{"key":"22543_CR20","doi-asserted-by":"publisher","first-page":"848370doi","DOI":"10.3389\/fpubh.2022.848370","volume":"10","author":"S Lee","year":"2022","unstructured":"Lee S, Kim MJ, Lee SH, Kim HY, Kim HS, Oh IH. Comparison of Disability-Adjusted life years (DALYs) and economic burden on people with Drug-Susceptible tuberculosis and Multidrug-Resistant tuberculosis in Korea. Front Public Health. 2022;10:848370doi. https:\/\/doi.org\/10.3389\/fpubh.2022.848370.","journal-title":"Front Public Health"},{"issue":"8","key":"22543_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3855\/jidc.5925","volume":"9","author":"A Sengul","year":"2015","unstructured":"Sengul A, Akturk UA, Aydemir Y, Kaya N, Kocak ND, Tasolar FT. Factors affecting successful treatment outcomes in pulmonary tuberculosis: a single-center experience in Turkey, 2005\u20132011. J Infect Dev Ctries. 2015;9(8):821\u20138. https:\/\/doi.org\/10.3855\/jidc.5925.","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"22543_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12879-018-3019-7","volume":"18","author":"Y Wen","year":"2018","unstructured":"Wen Y, Zhang Z, Li X, Xia D, Ma J, Dong Y, Zhang X. Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and negative tuberculosis patients in Anqing, China: a retrospective study. BMC Infect Dis. 2018;18(1):104. https:\/\/doi.org\/10.1186\/s12879-018-3019-7.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"22543_CR23","first-page":"61","volume":"79","author":"B Blomberg","year":"2001","unstructured":"Blomberg B, Spinaci S, Fourie B, Laing R. The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. Bull World Health Organ. 2001;79(1):61\u20138.","journal-title":"Bull World Health Organ"},{"key":"22543_CR24","doi-asserted-by":"publisher","DOI":"10.1089\/3dp.2021.0037","author":"TK Malakar","year":"2022","unstructured":"Malakar TK, Chaudhari VS, Dwivedy SK, Murty US, Banerjee S. Addit Manuf. 2022;9(6):535\u201346. https:\/\/doi.org\/10.1089\/3dp.2021.0037. 3D Printed Housing Devices for Segregated Compartmental Delivery of Oral Fixed-Dose Anti-Tubercular Drugs Adopting Print and Fill Strategy. 3D Print."},{"issue":"2","key":"22543_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1590\/S1806-37562016000000204","volume":"43","author":"VDD Silva","year":"2017","unstructured":"Silva VDD, Mello FCQ, Figueiredo SCA. Estimated rates of recurrence, cure, and treatment abandonment in patients with pulmonary tuberculosis treated with a -four-drug fixed-dose combination regimen at a tertiary health care facility in the City of Rio de Janeiro, Brazil. J Bras Pneumol. 2017;43(2):113\u201320. https:\/\/doi.org\/10.1590\/S1806-37562016000000204.","journal-title":"J Bras Pneumol"},{"issue":"4","key":"22543_CR26","first-page":"565","volume":"28","author":"Y Sun","year":"2020","unstructured":"Sun Y, Cao B, Rao W, Li X, Yu B, Zhang T, et al. Comparison of efficacy and safety of two fixed-dose combination regimens for tuberculosis in the Chinese population. Infez Med. 2020;28(4):565\u201371.","journal-title":"Infez Med"},{"key":"22543_CR27","unstructured":"World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Rep Geneva: 2014, 17\u201320."},{"issue":"7","key":"22543_CR28","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/TP.0000000000000543","volume":"99","author":"LA Dageforde","year":"2015","unstructured":"Dageforde LA, Box A, Feurer ID, Cavanaugh KL. Understanding patient barriers to kidney transplant evaluation. Transplantation. 2015;99(7):1463\u20139. https:\/\/doi.org\/10.1097\/TP.0000000000000543.","journal-title":"Transplantation"},{"issue":"30","key":"22543_CR29","doi-asserted-by":"publisher","first-page":"10545","DOI":"10.3748\/wjg.v20.i30.10545","volume":"20","author":"Y Yang","year":"2014","unstructured":"Yang Y, Zhao JC, Yan LN, Ma YK, Huang B, Yuan D, et al. Risk factors associated with early and late HAT after adult liver transplantation. World J Gastroenterol. 2014;20(30):10545\u201352. https:\/\/doi.org\/10.3748\/wjg.v20.i30.10545.","journal-title":"World J Gastroenterol"},{"key":"22543_CR30","doi-asserted-by":"publisher","first-page":"e2022045","DOI":"10.4178\/epih.e2022045","volume":"44","author":"J Zhang","year":"2022","unstructured":"Zhang J, Shen X, Yang C, Chen Y, Guo J, Wang D, et al. Spatial analysis of tuberculosis treatment outcomes in Shanghai: implications for tuberculosis control. Epidemiol Health. 2022;44:e2022045. https:\/\/doi.org\/10.4178\/epih.e2022045.","journal-title":"Epidemiol Health"},{"issue":"3","key":"22543_CR31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3126\/nje.v10i3.28397","volume":"10","author":"T Dorji","year":"2020","unstructured":"Dorji T, Wangdi K. Treatment outcome of tuberculosis patient of Samtse general hospital, Bhutan. Nepal J Epidemiol. 2020;10(3):888\u201396. https:\/\/doi.org\/10.3126\/nje.v10i3.28397.","journal-title":"Nepal J Epidemiol"},{"issue":"1","key":"22543_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s13104-018-3473-8","volume":"11","author":"M Atif","year":"2018","unstructured":"Atif M, Anwar Z, Fatima RK, Malik I, Asghar S, Scahill S. Analysis of tuberculosis treatment outcomes among pulmonary tuberculosis patients in Bahawalpur, Pakistan. BMC Res Notes. 2018;11(1):370. https:\/\/doi.org\/10.1186\/s13104-018-3473-8.","journal-title":"BMC Res Notes"},{"issue":"1","key":"22543_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3760\/cma.j.issn.1001-0939.2018.01.008","volume":"41","author":"YH Liu","year":"2018","unstructured":"Liu YH, Gao WW, Li L, Du J, Ma Y, Shu W, et al. The effectiveness of individualized treatment regimen on smear-positive retreatment pulmonary tuberculosis with mono-and poly-drug resistance. Zhonghua Jie He He Hu Xi Za Zhi. 2018;41(1):25\u201331. https:\/\/doi.org\/10.3760\/cma.j.issn.1001-0939.2018.01.008.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"5","key":"22543_CR34","first-page":"341","volume":"39","author":"MY Yang","year":"2013","unstructured":"Yang MY, Li CX, Xiang XD. Analyzing of treatment effect in recurrence of pulmonary tuberculosis for drug-resistant. J Mod Clin Med. 2013;39(5):341\u20132.","journal-title":"J Mod Clin Med"},{"issue":"5","key":"22543_CR35","doi-asserted-by":"publisher","first-page":"e10799","DOI":"10.1371\/journal.pone.0010799","volume":"5","author":"GX He","year":"2010","unstructured":"He GX, Xie YG, Wang LX, Borgdorff MW, van der Werf MJ, Fan JH, et al. Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment. PLoS ONE. 2010;5(5):e10799. https:\/\/doi.org\/10.1371\/journal.pone.0010799.","journal-title":"PLoS ONE"},{"issue":"6","key":"22543_CR36","doi-asserted-by":"publisher","first-page":"e0268290","DOI":"10.1371\/journal.pone.0268290","volume":"17","author":"HM Youn","year":"2022","unstructured":"Youn HM, Shin MK, Jeong D, Kim HJ, Choi H, Kang YA. Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study. PLoS ONE. 2022;17(6):e0268290. https:\/\/doi.org\/10.1371\/journal.pone.0268290.","journal-title":"PLoS ONE"},{"issue":"1","key":"22543_CR37","doi-asserted-by":"publisher","first-page":"1900322","DOI":"10.2807\/1560-7917.ES.2020.25.1.1900322","volume":"25","author":"M Stosic","year":"2020","unstructured":"Stosic M, Grujicic SS, Grgurevic A, Kuruc V, Ristic L, Antonijevic G, et al. Trends in tuberculosis notification and mortality and factors associated with treatment outcomes in Serbia, 2005 to 2015. Euro Surveill. 2020;25(1):1900322. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.1.1900322.","journal-title":"Euro Surveill"},{"issue":"1","key":"22543_CR38","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1038\/s41598-023-33245-5","volume":"13","author":"J Min","year":"2023","unstructured":"Min J, Park JS, Kim HW, Ko Y, Oh JY, Jeong YJ, et al. Differential effects of sex on tuberculosis location and severity across the lifespan. Sci Rep. 2023;13(1):6023. https:\/\/doi.org\/10.1038\/s41598-023-33245-5.","journal-title":"Sci Rep"},{"issue":"2","key":"22543_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4269\/ajtmh.2011.10-0630","volume":"85","author":"X Zhang","year":"2011","unstructured":"Zhang X, Andersen AB, Lillebaek T, Kamper-J\u00f8rgensen Z, Thomsen V\u00d8, Ladefoged K, et al. Effect of sex, age, and race on the clinical presentation of tuberculosis: a 15-year population-based study. Am J Trop Med Hyg. 2011;85(2):285\u201390. https:\/\/doi.org\/10.4269\/ajtmh.2011.10-0630.","journal-title":"Am J Trop Med Hyg"},{"key":"22543_CR40","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4102\/hsag.v24i0.1146","volume":"24","author":"J Wessels","year":"2019","unstructured":"Wessels J, Walsh CM, Nel M. Smoking habits and alcohol use of patients with tuberculosis at Standerton tuberculosis specialised hospital, Mpumalanga, South Africa. Health SA. 2019;24:1146. https:\/\/doi.org\/10.4102\/hsag.v24i0.1146.","journal-title":"Health SA"},{"issue":"2","key":"22543_CR41","doi-asserted-by":"publisher","first-page":"e0002596","DOI":"10.1371\/journal.pgph.0002596","volume":"4","author":"Y Hamada","year":"2024","unstructured":"Hamada Y, Quartagno M, Law I, Malik F, Bonsu FA, Adetifa IMO, et al. Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of National tuberculosis prevalence surveys: time for household-wide interventions? PLOS Glob Public Health. 2024;4(2):e0002596. https:\/\/doi.org\/10.1371\/journal.pgph.0002596.","journal-title":"PLOS Glob Public Health"},{"issue":"5","key":"22543_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jinf.2018.07.007","volume":"77","author":"KA Alene","year":"2018","unstructured":"Alene KA, Clements ACA, McBryde ES, Jaramillo E, L\u00f6nnroth K, Shaweno D, et al. Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis. J Infect. 2018;77(5):357\u201367. https:\/\/doi.org\/10.1016\/j.jinf.2018.07.007.","journal-title":"J Infect"},{"issue":"1","key":"22543_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s11556-021-00258-w","volume":"18","author":"S Zach","year":"2021","unstructured":"Zach S, Zeev A, Ophir M, Eilat-Adar S. Physical activity, resilience, emotions, moods, and weight control of older adults during the COVID-19 global crisis. Eur Rev Aging Phys Act. 2021;18(1):5. https:\/\/doi.org\/10.1186\/s11556-021-00258-w.","journal-title":"Eur Rev Aging Phys Act"},{"issue":"1","key":"22543_CR44","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.1038\/s41598-021-86994-6","volume":"11","author":"J Zhou","year":"2021","unstructured":"44.Zhou J, Ma X, Tian J, Hong F, Li J. Spatial distribution and risk factors of adverse treatment outcomes of tuberculosis in Guizhou, China, 2013\u20132018. Sci Rep. 2021;11(1):7706. https:\/\/doi.org\/10.1038\/s41598-021-86994-6.","journal-title":"Sci Rep"},{"issue":"1","key":"22543_CR45","doi-asserted-by":"publisher","first-page":"e24830","DOI":"10.2196\/24830","volume":"7","author":"H Jiang","year":"2021","unstructured":"Jiang H, Zhang G, Yin J, Zhao D, Liu F, Yao Y, et al. Assessment of strategies and epidemiological characteristics of tuberculosis in Henan Province, China: observational study. JMIR Public Health Surveill. 2021;7(1):e24830. https:\/\/doi.org\/10.2196\/24830.","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"22543_CR46","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1186\/s12889-020-10005-y","volume":"20","author":"SM Awaluddin","year":"2020","unstructured":"Awaluddin SM, Ismail N, Zakaria Y, Yasin SM, Razali A, Mutalip MHA, et al. Characteristics of paediatric patients with tuberculosis and associated determinants of treatment success in Malaysia using the MyTB version 2.1 database over five years. BMC Public Health. 2020;20(1):1903. https:\/\/doi.org\/10.1186\/s12889-020-10005-y.","journal-title":"BMC Public Health"},{"issue":"2","key":"22543_CR47","doi-asserted-by":"publisher","first-page":"e0011968","DOI":"10.1371\/journal.pntd.0011968","volume":"18","author":"BJ Njiro","year":"2024","unstructured":"Njiro BJ, Kisonga R, Joachim C, Sililo GA, Nkiligi E, Ibisomi L, et al. Epidemiology and treatment outcomes of recurrent tuberculosis in Tanzania from 2018 to 2021 using the National TB dataset. PLoS Negl Trop Dis. 2024;18(2):e0011968. https:\/\/doi.org\/10.1371\/journal.pntd.0011968.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"22543_CR48","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s12879-018-3574-y","volume":"18","author":"J Mok","year":"2018","unstructured":"Mok J, An D, Kim S, Lee M, Kim C, Son H. Treatment outcomes and factors affecting treatment outcomes of new patients with tuberculosis in Busan, South Korea: a retrospective study of a citywide registry, 2014\u20132015. BMC Infect Dis. 2018;18(1):655. https:\/\/doi.org\/10.1186\/s12879-018-3574-y.","journal-title":"BMC Infect Dis"},{"issue":"04","key":"22543_CR49","doi-asserted-by":"publisher","first-page":"456","DOI":"10.13604\/j.cnki.46-1064\/r.2024.04.17","volume":"24","author":"LG Yang","year":"2024","unstructured":"Yang LG, Ma XL, Fan B, et al. Analysis of factors influencing treatment outcomes in pulmonary tuberculosis patients of the Xinjiang production and construction corps. Chin Trop Med. 2024;24(04):456\u201362. https:\/\/doi.org\/10.13604\/j.cnki.46-1064\/r.2024.04.17.","journal-title":"Chin Trop Med"},{"issue":"11","key":"22543_CR50","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.16506\/j.1009-6639.2024.11.010","volume":"25","author":"YB Ma","year":"2024","unstructured":"Ma YB, Zhao JX, Bai YE, et al. Analysis of factors influencing treatment outcomes in pulmonary tuberculosis patients in Gansu Province from 2018 to 2022. Chin J Prev Med. 2024;25(11):1400\u20133. https:\/\/doi.org\/10.16506\/j.1009-6639.2024.11.010.","journal-title":"Chin J Prev Med"},{"issue":"1","key":"22543_CR51","doi-asserted-by":"publisher","first-page":"2399273","DOI":"10.1080\/22221751.2024.2399273","volume":"13","author":"Z Quan","year":"2024","unstructured":"Quan Z, Xu J, Li M, Cheng C, Mijiti P, Jiang Q, Takiff H, Ren Z, Gao Q. Transmission of tuberculosis in rural Henan, China: a prospective population-based genomic Spatial epidemiological study. Emerg Microbes Infect. 2024;13(1):2399273. https:\/\/doi.org\/10.1080\/22221751.2024.2399273.","journal-title":"Emerg Microbes Infect"},{"key":"22543_CR52","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2147\/NDT.S347579","volume":"18","author":"R Shen","year":"2022","unstructured":"Shen R, Zong K, Liu J, Zhang L. Risk factors for depression in tuberculosis patients: A Meta-Analysis. Neuropsychiatr Dis Treat. 2022;18:847\u201366. https:\/\/doi.org\/10.2147\/NDT.S347579.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"22543_CR53","doi-asserted-by":"publisher","first-page":"1134036","DOI":"10.3389\/fcimb.2023.1134036","volume":"13","author":"MK Bisht","year":"2023","unstructured":"Bisht MK, Dahiya P, Ghosh S, Mukhopadhyay S. The cause-effect relation of tuberculosis on incidence of diabetes mellitus. Front Cell Infect Microbiol. 2023;13:1134036. https:\/\/doi.org\/10.3389\/fcimb.2023.1134036.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"22543_CR54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1590\/s1806-37562017000000443","volume":"44","author":"DR Silva","year":"2018","unstructured":"Silva DR, Mu\u00f1oz-Torrico M, Duarte R, Galv\u00e3o T, Bonini EH, Arbex FF, et al. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol. 2018;44(2):145\u201352. https:\/\/doi.org\/10.1590\/s1806-37562017000000443.","journal-title":"J Bras Pneumol"},{"issue":"11","key":"22543_CR55","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/1753-0407.13444","volume":"15","author":"Y Ling","year":"2023","unstructured":"Ling Y, Chen X, Zhou M, Zhang M, Luo D, Wang W, et al. The effect of diabetes mellitus on tuberculosis in Eastern China: A decision-tree analysis based on a real-world study. J Diabetes. 2023;15(11):920\u201330. https:\/\/doi.org\/10.1111\/1753-0407.13444.","journal-title":"J Diabetes"},{"key":"22543_CR56","doi-asserted-by":"publisher","first-page":"8298291","DOI":"10.1155\/2020\/8298291","volume":"2020","author":"DF Kouemo Motse","year":"2020","unstructured":"Kouemo Motse DF, Nsagha DS, Adiogo D, Kojom Foko LP, Teyim PM, Chichom-Mefire A, et al. Tuberculosis chemotherapy outcome in the Littoral region of Cameroon: A Meta-analysis of treatment success rate between 2014 and 2016. Biomed Res Int. 2020;2020:8298291. https:\/\/doi.org\/10.1155\/2020\/8298291.","journal-title":"Biomed Res Int"},{"issue":"10","key":"22543_CR57","doi-asserted-by":"publisher","first-page":"e0205601","DOI":"10.1371\/journal.pone.0205601","volume":"13","author":"M Verdecchia","year":"2018","unstructured":"Verdecchia M, Keus K, Blankley S, Vambe D, Ssonko C, Piening T, et al. Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011\u20132013. PLoS ONE. 2018;13(10):e0205601. https:\/\/doi.org\/10.1371\/journal.pone.0205601.","journal-title":"PLoS ONE"},{"issue":"1","key":"22543_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/thorax.55.1.32","volume":"55","author":"E Hnizdo","year":"2000","unstructured":"Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55(1):32\u20138. https:\/\/doi.org\/10.1136\/thorax.55.1.32.","journal-title":"Thorax"},{"issue":"11","key":"22543_CR59","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1590\/s1806-37132008001100012","volume":"34","author":"CE Barboza","year":"2008","unstructured":"Barboza CE, Winter DH, Seiscento M, Santos Ude P, Terra Filho M. Tuberculosis and silicosis: epidemiology, diagnosis and chemoprophylaxis. J Bras Pneumol. 2008;34(11):959\u201366. https:\/\/doi.org\/10.1590\/s1806-37132008001100012.","journal-title":"J Bras Pneumol"},{"issue":"7","key":"22543_CR60","first-page":"401","volume":"94","author":"S Toujani","year":"2016","unstructured":"Toujani S, Ben Safta B, Ben Salah N, Mjid M, Ouahchi Y, Louzir B, et al. Contribution of fixed-dose combinations in the treatment of tuberculosis. Tunis Med. 2016;94(7):401\u20135.","journal-title":"Tunis Med"},{"key":"22543_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12879-015-0820-4","volume":"15","author":"JU Braga","year":"2015","unstructured":"Braga JU, Trajman A. Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC\u2009+\u2009Z for tuberculosis treatment in Brazil: a cohort study. BMC Infect Dis. 2015;15:81. https:\/\/doi.org\/10.1186\/s12879-015-0820-4.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22543-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22543-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22543-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T01:28:26Z","timestamp":1744334906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22543-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22543"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22543-4","relation":{"references":[{"id-type":"doi","id":"10.1089\/3dp.2021.0037","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4236966\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the authors declared that there was no conflict of interest in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1360"}}